Background. Since 2017, a global resurgence of measles cases has been affecting all regions of the world. In global immunisation surveys, coverage for the second dose of measles-containing vaccine (MCV2) was 69%, with significant variability between ...
from Google Alert - health https://ift.tt/2YZ3jvk
via IFTTT
0 comments:
Post a Comment